Issues relating to prequalified vaccines
Information concerning issues relating to prequalified vaccines can be found at the links below.
-
Statement on Rotarix® and Vaccine Vial Monitor (VVM) compliance
pdf, 37kb
22 February 2017 -
Notice of Concern. Rabbies vaccine (Lyssavac) Cadila Healthcare Limited
29 January 2016 -
WHO statement on risks and benefits of rotavirus vaccines Rotarix and RotaTeq
6 May 2015 -
Update on two-dose presentation of preservative-free Human Papilloma Vaccine from GlaxoSmithKline (GSK) (Cervarix™)
6 February 2013 -
Suspension of Statens Serum Institute IPV supply through UN procurement
29 November 2012 -
Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
14 May 2012